Colevas AD - Search Results

1

Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.

Haddad R, Concha-Benavente F, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Kasper S, Vokes EE, Worden F, Saba NF, Tahara M, Jayaprakash V, Lynch M, Li L, Gillison ML, Harrington KJ, Ferris RL. Haddad R, et al. Among authors: colevas ad. Cancer. 2019 Sep 15;125(18):3208-3218. doi: 10.1002/cncr.32190. Epub 2019 Jun 27. Cancer. 2019. PMID: 31246283 Free PMC article. Clinical Trial.

2

Induction chemotherapy in the management of squamous cell cancer of the head and neck.

Posner MR, Colevas AD. Posner MR, et al. Among authors: colevas ad. Cancer J Sci Am. 1997 Mar-Apr;3(2):73-5. Cancer J Sci Am. 1997. PMID: 9099455 No abstract available.

3

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.

Clark JR, Busse PM, Norris CM Jr, Andersen JW, Dreyfuss AI, Rossi RM, Poulin MD, Colevas AD, Tishler RB, Costello R, Lucarini JW, Lucarini D, Thornhill L, Lackey M, Peters E, Posner MR. Clark JR, et al. Among authors: colevas ad. J Clin Oncol. 1997 Sep;15(9):3100-10. doi: 10.1200/JCO.1997.15.9.3100. J Clin Oncol. 1997. PMID: 9294473

4

Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.

Colevas AD. Colevas AD. Oncology (Williston Park). 1997 Sep;11(9 Suppl 10):86-9. Oncology (Williston Park). 1997. PMID: 9348576 Review.

5

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.

Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR. Colevas AD, et al. J Clin Oncol. 1998 Apr;16(4):1331-9. doi: 10.1200/JCO.1998.16.4.1331. J Clin Oncol. 1998. PMID: 9552034 Clinical Trial.

6

Docetaxel in head and neck cancer: a review.

Colevas AD, Posner MR. Colevas AD, et al. Am J Clin Oncol. 1998 Oct;21(5):482-6. doi: 10.1097/00000421-199810000-00013. Am J Clin Oncol. 1998. PMID: 9781605 Review.

7

A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck.

Colevas AD, Adak S, Amrein PC, Barton JJ, Costello R, Posner MR. Colevas AD, et al. Ann Oncol. 2000 May;11(5):535-9. doi: 10.1023/a:1008355413788. Ann Oncol. 2000. PMID: 10907945 Free article. Clinical Trial.

8

The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.

Posner MR, Colevas AD, Tishler RB. Posner MR, et al. Among authors: colevas ad. Semin Oncol. 2000 Aug;27(4 Suppl 8):13-24. Semin Oncol. 2000. PMID: 10952434 Review.

9

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck.

Posner MR, Glisson B, Frenette G, Al-Sarraf M, Colevas AD, Norris CM, Seroskie JD, Shin DM, Olivares R, Garay CA. Posner MR, et al. Among authors: colevas ad. J Clin Oncol. 2001 Feb 15;19(4):1096-104. doi: 10.1200/JCO.2001.19.4.1096. J Clin Oncol. 2001. PMID: 11181674 Clinical Trial.

10

A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.

Colevas AD, Amrein PC, Gomolin H, Barton JJ, Read RR, Adak S, Benner S, Costello R, Posner MR. Colevas AD, et al. Cancer. 2001 Jul 15;92(2):326-31. doi: 10.1002/1097-0142(20010715)92:2<326::aid-cncr1326>3.0.co;2-w. Cancer. 2001. PMID: 11466686 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page